Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Improving Cognition in Schizophrenia Using tDCS [NA]
A UCLA-sponsored clinical trial investigated whether transcranial direct current stimulation could improve cognition in schizophrenia; resul…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Pharmacovigilance in Gerontopsychiatric Patients [Phase 3]
A Phase 3 pharmacovigilance trial in gerontopsychiatric patients has been terminated; the study focused on dementia and depression with rela…
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: SCIT Versus TAR for Outpatients With Schizophrenia [NA]
A completed clinical trial comparing SCIT versus TAR for outpatients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia [Phase 4]
A Phase 4 pilot trial evaluating valproate as an adjunctive treatment for Toxoplasma gondii infection in early course schizophrenia has been…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants [Phase 1]
Phase 1 trial update for TAK-831-1001 in healthy participants; the study was terminated with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Novel Smoking Cessation Drug for Schizophrenia [Phase 2]
Phase 2 trial update for a novel smoking cessation drug studied in schizophrenia, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia [Phase 2]
Phase 2 clinical trial update for DAAOI-2 as add-on treatment in treatment-resistant schizophrenia completed.
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Biomarker Study of Acamprosate in Schizophrenia [Phase 4]
Phase 4 biomarker study investigating acamprosate in schizophrenia and schizoaffective disorder; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Computerized Cognitive Training for Schizophrenia in Brazil [Phase 3]
Phase 3 clinical trial evaluating computerized cognitive training for schizophrenia in Brazil.
-
CLINICAL_TRIALS trial_result · 2018-01-02Clinical Trial Update: Staccato Loxapine in Agitation (Proof of Concept) [Phase 2]
Phase 2 proof-of-concept trial assessing Staccato Loxapine for agitation in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-20Clinical Trial Update: Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo [Phase 2]
Phase 2 randomized trial evaluating PF-02545920 vs placebo for schizophrenia was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-20Clinical Trial Update: Neurophysiological Targets for Cognitive Training in Schizophrenia [NA]
Completed trial evaluating neurophysiological targets for cognitive training in schizophrenia; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Cognitive-Behavioral Therapy in Veterans With Schizophrenia [NA]
This clinical trial update reports results from a cognitive-behavioral therapy program for veterans with schizophrenia or schizoaffective di…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Add-on Methotrexate for the Treatment of Schizophrenia [Phase 2]
A Phase 2 trial is evaluating add-on methotrexate for schizophrenia; no clinical results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Varenicline Adjunctive Treatment in Schizophrenia [Phase 4]
Phase 4 trial update on varenicline as an adjunctive treatment in schizophrenia and related disorders completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating pioglitazone for lipid and glucose abnormalities in patients with schizophrenia has completed, with resu…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode [NA]
This completed clinical trial evaluated whether combining exercise with cognitive training improves cognitive and functional outcomes after …
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses [NA]
This ClinicalTrials.gov update indicates that the Johns Hopkins University-sponsored trial 'Peer Support for Increasing Physical Activity in…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors [Phase 4]
A Phase 4 clinical trial assessing varenicline for cognitive deficits and cigarette smoking in schizophrenia reports efficacy findings and p…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal [Phase 4]
A Phase 4 trial assessing functional brain imaging and employment outcomes in first-episode schizophrenia patients treated with Risperdal ha…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Risperidone LA Heathcare Resource Study [Phase 4]
A Phase 4 post-marketing study of risperidone long-acting injectable conducted by the University of British Columbia has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Task Sharing for the Care of Severe Mental Disorders in a Low-income Country [Phase 3]
A Phase 3 trial evaluating a task-sharing care model for schizophrenia, bipolar disorder, major depressive disorder, and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia [NA]
Clinical trial of Withania Somnifera as an immunomodulator and anti-inflammatory agent for schizophrenia and schizoaffective disorder has co…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Evaluation of Metamemory in Patients With Schizophrenia [NA]
This document reports the completion status of a clinical trial evaluating metamemory in patients with schizophrenia; aging is listed as a r…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia [Phase 2]
A Phase 2 trial evaluating a galantamine and memantine combination for cognitive impairments in schizophrenia was terminated, with results p…